Compare Mutual Funds
Pros | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Among most bought funds within the category. | ||
Cons | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. | - |
INDMoney rank | 8/8 | 3/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 13 Years 8 Months | 8 Years 1 Months | ||
Fund AUM | ₹9044 Cr | ₹6625 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.79% | 0.87% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 37 | 40 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 1 | 2 | ||
Top 3 Sectors | Health (100%) |
| ||
Equity % | 97.92% | 99.82% | ||
Debt % | - | - | ||
P/E | 38.2 | 36.95 | ||
P/B | 5.65 | 4.44 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 4.91% | 5.28% | ||
3-Month Return | 13.89% | 16.15% | ||
6-Month Return | 12% | 12.2% | ||
1-Year Return | 9.79% | 9.76% | ||
3-Year Return | 21.4% | 26.29% | ||
5-Year Return | 13.58% | 16.86% |
Sharpe | 0.97 | 1.14 | ||
Alpha | -0.78 | 2.11 | ||
Beta | 0.89 | 0.96 | ||
Standard Deviation | 15.23 | 16.45 | ||
Information Ratio | -0.76 | 0.42 |
Description | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Sailesh Raj Bhan, Kinjal Desai, Amber Singhania | Dharmesh Kakkad, Sharmila D’mello |

